The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Article 8

5 Feb 2018 14:34

RNS Number : 9526D
Skandinaviska Enskilda Banken
05 February 2018
 

 

 

 

 

ARTICLE 8 NOTIFICATION

 

 

 

 

 

Skandinaviska Enskilda Banken AB (publ) (the "Issuer")

This notification refers to:

 

(1) the Base Prospectus dated 20 July 2017 (the Base Prospectus) for notes to

be issued by the Issuer;

 

(2) the supplementary prospectuses dated 09 November 2017 (the Supplements); and

 

(3) the Final Terms dated 17 January 2018 (the Final Terms) in respect of the Issue

of EUR 990.000 (Fixed Rate and Credit Linked Redemption due 16 January 2023 Series SNP642 (the Note Issue),

the Base Prospectus as completed by the Final Terms and the Supplements to it, together

constituting a base prospectus for the purposes of Directive 2003/71/EC and Directive

2010/73/EU (the Prospectus Directive).

 

Pursuant to our obligations under Article 8 of the Prospectus Directive, we confirm in respect

of the Note Issue the following information:

 

Final Aggregate Nominal Amount: EUR 990.000

 

This announcement has been issued through the Companies Announcement Service of

The Irish Stock Exchange

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEFKPDNQBKDDBK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.